nodes	percent_of_prediction	percent_of_DWPC	metapath
Zolpidem—GABRA2—conduct disorder	0.923	1	CbGaD
Zolpidem—GABRB2—GABA A receptor activation—GABRA2—conduct disorder	0.00497	0.0643	CbGpPWpGaD
Zolpidem—GABRA3—GABA A receptor activation—GABRA2—conduct disorder	0.00474	0.0613	CbGpPWpGaD
Zolpidem—GABRB3—GABA A receptor activation—GABRA2—conduct disorder	0.00463	0.0599	CbGpPWpGaD
Zolpidem—GABRG2—GABA A receptor activation—GABRA2—conduct disorder	0.00454	0.0588	CbGpPWpGaD
Zolpidem—GABRA1—GABA A receptor activation—GABRA2—conduct disorder	0.00397	0.0514	CbGpPWpGaD
Zolpidem—GABRB2—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00304	0.0394	CbGpPWpGaD
Zolpidem—GABRA3—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.0029	0.0376	CbGpPWpGaD
Zolpidem—GABRB3—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00283	0.0367	CbGpPWpGaD
Zolpidem—GABRG2—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00278	0.036	CbGpPWpGaD
Zolpidem—GABRA1—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.00243	0.0315	CbGpPWpGaD
Zolpidem—GABRB2—GABA receptor activation—GABRA2—conduct disorder	0.00161	0.0209	CbGpPWpGaD
Zolpidem—GABRA3—GABA receptor activation—GABRA2—conduct disorder	0.00154	0.0199	CbGpPWpGaD
Zolpidem—GABRB3—GABA receptor activation—GABRA2—conduct disorder	0.0015	0.0195	CbGpPWpGaD
Zolpidem—GABRG2—GABA receptor activation—GABRA2—conduct disorder	0.00148	0.0191	CbGpPWpGaD
Zolpidem—GABRA1—GABA receptor activation—GABRA2—conduct disorder	0.00129	0.0167	CbGpPWpGaD
Zolpidem—CYP1A2—Methylation—COMT—conduct disorder	0.000944	0.0122	CbGpPWpGaD
Zolpidem—GABRB2—Orphan transporters—GABRA2—conduct disorder	0.000941	0.0122	CbGpPWpGaD
Zolpidem—GABRA3—Orphan transporters—GABRA2—conduct disorder	0.000898	0.0116	CbGpPWpGaD
Zolpidem—GABRB3—Orphan transporters—GABRA2—conduct disorder	0.000877	0.0113	CbGpPWpGaD
Zolpidem—GABRG2—Orphan transporters—GABRA2—conduct disorder	0.000861	0.0111	CbGpPWpGaD
Zolpidem—GABRA1—Orphan transporters—GABRA2—conduct disorder	0.000752	0.00974	CbGpPWpGaD
Zolpidem—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000742	0.0096	CbGpPWpGaD
Zolpidem—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000708	0.00916	CbGpPWpGaD
Zolpidem—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000691	0.00895	CbGpPWpGaD
Zolpidem—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000679	0.00878	CbGpPWpGaD
Zolpidem—GABRB2—Ion channel transport—GABRA2—conduct disorder	0.00066	0.00855	CbGpPWpGaD
Zolpidem—GABRA3—Ion channel transport—GABRA2—conduct disorder	0.00063	0.00815	CbGpPWpGaD
Zolpidem—GABRB3—Ion channel transport—GABRA2—conduct disorder	0.000615	0.00796	CbGpPWpGaD
Zolpidem—GABRG2—Ion channel transport—GABRA2—conduct disorder	0.000604	0.00782	CbGpPWpGaD
Zolpidem—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.000593	0.00768	CbGpPWpGaD
Zolpidem—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.00059	0.00764	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000558	0.00722	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000532	0.00689	CbGpPWpGaD
Zolpidem—GABRA1—Ion channel transport—GABRA2—conduct disorder	0.000528	0.00683	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000519	0.00672	CbGpPWpGaD
Zolpidem—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.000513	0.00664	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00051	0.0066	CbGpPWpGaD
Zolpidem—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.000472	0.00611	CbGpPWpGaD
Zolpidem—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.000455	0.00589	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.000446	0.00577	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—GABRA2—conduct disorder	0.000427	0.00553	CbGpPWpGaD
Zolpidem—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000416	0.00539	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—GABRA2—conduct disorder	0.000408	0.00528	CbGpPWpGaD
Zolpidem—PTGS1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000403	0.00522	CbGpPWpGaD
Zolpidem—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.0004	0.00518	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—GABRA2—conduct disorder	0.000398	0.00515	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—GABRA2—conduct disorder	0.000391	0.00506	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.000345	0.00447	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—GABRA2—conduct disorder	0.000342	0.00442	CbGpPWpGaD
Zolpidem—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000301	0.00389	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000268	0.00348	CbGpPWpGaD
Zolpidem—GABRB2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000267	0.00345	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00026	0.00337	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—COMT—conduct disorder	0.000256	0.00332	CbGpPWpGaD
Zolpidem—GABRA3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000254	0.00329	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000252	0.00326	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—COMT—conduct disorder	0.00025	0.00324	CbGpPWpGaD
Zolpidem—GABRA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00025	0.00324	CbGpPWpGaD
Zolpidem—GABRB3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000248	0.00321	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—COMT—conduct disorder	0.000246	0.00318	CbGpPWpGaD
Zolpidem—GABRG2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000244	0.00316	CbGpPWpGaD
Zolpidem—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000233	0.00301	CbGpPWpGaD
Zolpidem—GABRB2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00023	0.00297	CbGpPWpGaD
Zolpidem—CYP3A7—Biological oxidations—COMT—conduct disorder	0.000223	0.00288	CbGpPWpGaD
Zolpidem—CYP3A7—Biological oxidations—MAOA—conduct disorder	0.000221	0.00286	CbGpPWpGaD
Zolpidem—CYP3A7—Metapathway biotransformation—COMT—conduct disorder	0.00022	0.00284	CbGpPWpGaD
Zolpidem—GABRA3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000219	0.00284	CbGpPWpGaD
Zolpidem—PTGS1—Biological oxidations—COMT—conduct disorder	0.000216	0.00279	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000215	0.00278	CbGpPWpGaD
Zolpidem—PTGS1—Biological oxidations—MAOA—conduct disorder	0.000214	0.00277	CbGpPWpGaD
Zolpidem—GABRB3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000214	0.00277	CbGpPWpGaD
Zolpidem—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000214	0.00277	CbGpPWpGaD
Zolpidem—GABRA1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000213	0.00276	CbGpPWpGaD
Zolpidem—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000212	0.00275	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000212	0.00274	CbGpPWpGaD
Zolpidem—GABRG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00021	0.00272	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—COMT—conduct disorder	0.000206	0.00266	CbGpPWpGaD
Zolpidem—GABRB2—Neuronal System—MAOA—conduct disorder	0.000204	0.00264	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—COMT—conduct disorder	0.000196	0.00254	CbGpPWpGaD
Zolpidem—GABRA3—Neuronal System—MAOA—conduct disorder	0.000195	0.00252	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—COMT—conduct disorder	0.000193	0.0025	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—COMT—conduct disorder	0.000192	0.00248	CbGpPWpGaD
Zolpidem—GABRA2—Neuronal System—MAOA—conduct disorder	0.000191	0.00248	CbGpPWpGaD
Zolpidem—GABRB3—Neuronal System—MAOA—conduct disorder	0.00019	0.00246	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—COMT—conduct disorder	0.000188	0.00244	CbGpPWpGaD
Zolpidem—GABRG2—Neuronal System—MAOA—conduct disorder	0.000187	0.00242	CbGpPWpGaD
Zolpidem—GABRA1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000184	0.00238	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000184	0.00238	CbGpPWpGaD
Zolpidem—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000181	0.00235	CbGpPWpGaD
Zolpidem—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.000166	0.00215	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—COMT—conduct disorder	0.000164	0.00213	CbGpPWpGaD
Zolpidem—GABRA1—Neuronal System—MAOA—conduct disorder	0.000163	0.00211	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—COMT—conduct disorder	0.000161	0.00208	CbGpPWpGaD
Zolpidem—CYP3A5—Biological oxidations—MAOA—conduct disorder	0.00016	0.00207	CbGpPWpGaD
Zolpidem—CYP3A5—Metapathway biotransformation—COMT—conduct disorder	0.000159	0.00205	CbGpPWpGaD
Zolpidem—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00014	0.00181	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—COMT—conduct disorder	0.000124	0.00161	CbGpPWpGaD
Zolpidem—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.000124	0.0016	CbGpPWpGaD
Zolpidem—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.000123	0.00159	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000119	0.00155	CbGpPWpGaD
Zolpidem—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000119	0.00155	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—COMT—conduct disorder	0.000114	0.00148	CbGpPWpGaD
Zolpidem—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000114	0.00147	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—COMT—conduct disorder	0.000113	0.00147	CbGpPWpGaD
Zolpidem—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000113	0.00146	CbGpPWpGaD
Zolpidem—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.000113	0.00146	CbGpPWpGaD
Zolpidem—GABRA1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000112	0.00145	CbGpPWpGaD
Zolpidem—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.000112	0.00145	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000106	0.00137	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—COMT—conduct disorder	9.69e-05	0.00126	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	9.65e-05	0.00125	CbGpPWpGaD
Zolpidem—CYP1A2—Biological oxidations—MAOA—conduct disorder	9.63e-05	0.00125	CbGpPWpGaD
Zolpidem—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	9.56e-05	0.00124	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—CGA—conduct disorder	8.43e-05	0.00109	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	8.25e-05	0.00107	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—CGA—conduct disorder	8.18e-05	0.00106	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—COMT—conduct disorder	7.48e-05	0.000969	CbGpPWpGaD
Zolpidem—CYP3A4—Biological oxidations—MAOA—conduct disorder	7.43e-05	0.000962	CbGpPWpGaD
Zolpidem—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	7.38e-05	0.000955	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—CGA—conduct disorder	6.1e-05	0.000789	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—CGA—conduct disorder	4.71e-05	0.00061	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—CGA—conduct disorder	4.34e-05	0.000561	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—CGA—conduct disorder	4.3e-05	0.000556	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—COMT—conduct disorder	3.81e-05	0.000493	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—MAOA—conduct disorder	3.78e-05	0.000489	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—COMT—conduct disorder	3.69e-05	0.000478	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—CGA—conduct disorder	3.67e-05	0.000475	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—MAOA—conduct disorder	3.66e-05	0.000474	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	3.55e-05	0.00046	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—CGA—conduct disorder	2.83e-05	0.000367	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—COMT—conduct disorder	2.75e-05	0.000356	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—MAOA—conduct disorder	2.73e-05	0.000354	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—COMT—conduct disorder	2.13e-05	0.000275	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—MAOA—conduct disorder	2.11e-05	0.000274	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	2.05e-05	0.000265	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—COMT—conduct disorder	1.96e-05	0.000253	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—MAOA—conduct disorder	1.94e-05	0.000252	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—COMT—conduct disorder	1.94e-05	0.000251	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—MAOA—conduct disorder	1.93e-05	0.000249	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.87e-05	0.000242	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—COMT—conduct disorder	1.66e-05	0.000215	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—MAOA—conduct disorder	1.65e-05	0.000213	CbGpPWpGaD
Zolpidem—CYP3A7—Metabolism—EP300—conduct disorder	1.63e-05	0.000211	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	1.6e-05	0.000207	CbGpPWpGaD
Zolpidem—PTGS1—Metabolism—EP300—conduct disorder	1.58e-05	0.000205	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—COMT—conduct disorder	1.28e-05	0.000166	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—MAOA—conduct disorder	1.27e-05	0.000164	CbGpPWpGaD
Zolpidem—CYP3A5—Metabolism—EP300—conduct disorder	1.18e-05	0.000153	CbGpPWpGaD
Zolpidem—CYP2C19—Metabolism—EP300—conduct disorder	9.13e-06	0.000118	CbGpPWpGaD
Zolpidem—CYP2D6—Metabolism—EP300—conduct disorder	8.39e-06	0.000109	CbGpPWpGaD
Zolpidem—CYP2C9—Metabolism—EP300—conduct disorder	8.32e-06	0.000108	CbGpPWpGaD
Zolpidem—CYP1A2—Metabolism—EP300—conduct disorder	7.11e-06	9.2e-05	CbGpPWpGaD
Zolpidem—CYP3A4—Metabolism—EP300—conduct disorder	5.49e-06	7.1e-05	CbGpPWpGaD
